Revenue
No reported data
Cell Source, Inc. (CLCS)
Price—Loading quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
Free cash flow
2013
2014
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
Financial statements
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research & development | — | — | $1.9M | $1.3M | $834,943 | $2.5M | $274,937 | $637,318 | $392,925 | $806,157 | $351,513 |
| Operating expenses | $3.8M | $4.3M | $4.2M | $4.0M | $3.6M | $3.8M | $2.0M | $2.3M | $2.3M | $4.1M | $1.5M |
| Operating income | −$3.8M | −$4.3M | −$4.2M | −$4.0M | −$3.6M | −$3.8M | −$2.0M | −$2.3M | — | — | — |
| Net income | −$4.5M | −$5.3M | −$5.2M | −$5.5M | −$4.6M | −$4.5M | −$2.1M | −$3.1M | −$2.5M | −$4.1M | −$1.8M |
| Basic EPSper diluted share | -$0.14 | -$0.17 | -$0.18 | -$0.19 | -$0.19 | -$0.18 | $0.09 | -$0.12 | -$0.10 | -$0.18 | -$0.14 |
| Diluted EPSper diluted share | -$0.14 | -$0.17 | -$0.18 | -$0.19 | -$0.19 | -$0.18 | $0.09 | -$0.12 | -$0.10 | -$0.18 | -$0.14 |